DK0439059T3 - 1-phenylalkyl-3-phenylurinstofderivat - Google Patents

1-phenylalkyl-3-phenylurinstofderivat

Info

Publication number
DK0439059T3
DK0439059T3 DK91100515.5T DK91100515T DK0439059T3 DK 0439059 T3 DK0439059 T3 DK 0439059T3 DK 91100515 T DK91100515 T DK 91100515T DK 0439059 T3 DK0439059 T3 DK 0439059T3
Authority
DK
Denmark
Prior art keywords
phenylalkyl
integer
alkyl
phenylurea derivative
alkoxyl
Prior art date
Application number
DK91100515.5T
Other languages
Danish (da)
English (en)
Inventor
Tetsuo Sekiya
Shinya Inoue
Kohei Umezu
Hiromi Okushima
Chiaki Hyodo
Kazuo Suzuki
Original Assignee
Mitsubishi Chem Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Chem Corp filed Critical Mitsubishi Chem Corp
Application granted granted Critical
Publication of DK0439059T3 publication Critical patent/DK0439059T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D321/00—Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
    • C07D321/02—Seven-membered rings
    • C07D321/10—Seven-membered rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
DK91100515.5T 1990-01-22 1991-01-17 1-phenylalkyl-3-phenylurinstofderivat DK0439059T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1223590 1990-01-22
JP2876890 1990-02-08

Publications (1)

Publication Number Publication Date
DK0439059T3 true DK0439059T3 (da) 1994-12-19

Family

ID=26347808

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91100515.5T DK0439059T3 (da) 1990-01-22 1991-01-17 1-phenylalkyl-3-phenylurinstofderivat

Country Status (10)

Country Link
US (1) US5202351A (fr)
EP (1) EP0439059B1 (fr)
JP (1) JPH05310678A (fr)
KR (1) KR910014366A (fr)
AT (1) ATE110375T1 (fr)
AU (1) AU636946B2 (fr)
CA (1) CA2034673A1 (fr)
DE (1) DE69103535T2 (fr)
DK (1) DK0439059T3 (fr)
ES (1) ES2057608T3 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL100915A (en) * 1991-02-19 1996-03-31 Erba Carlo Spa Double-transformed urea and theories, their preparation and pharmaceutical preparations containing them
WO1993024458A1 (fr) * 1992-05-28 1993-12-09 Pfizer Inc. Nouveau derives n-aryle et de n-heteroaryluree en tant qu'inhibiteurs de l'acylcoenzime a: cholesterol acyltransferase (acat)
CA2107196A1 (fr) * 1992-09-29 1994-03-30 Mitsubishi Chemical Corporation Derives de carboxamide
US5534529A (en) * 1993-06-30 1996-07-09 Sankyo Company, Limited Substituted aromatic amides and ureas derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses
US6133326A (en) 1994-08-31 2000-10-17 Pfizer Inc Compositions and methods for decreasing sebum production
HUP9602538A3 (en) 1995-09-18 1997-08-28 Sankyo Co New urea and amide derivatives having acat inhibitory activity, their preparation and their use
CA2190041A1 (fr) * 1995-11-13 1997-05-14 Shinya Inoue Derives de l'uree
GEP20043286B (en) * 2000-02-02 2004-07-26 Warner Lambert Co Dual Inhibitors of Cholesteryl Ester and Wax Ester Synthesis for Sebaceous Gland Disorders
CA2551056A1 (fr) 2003-11-07 2005-05-19 F. Hoffmann-La Roche Ag Derives de benzo [b][1,4] dioxepine

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2485600A (en) * 1946-04-01 1949-10-25 Harold W Moburg Derivatives of safrol and isosafrol
FR6183M (fr) * 1967-03-10 1968-07-15
US4102673A (en) * 1971-06-21 1978-07-25 Hercules Incorporated 1-Phenyl-hexyl ureas as herbicides
JPS5312844A (en) * 1976-07-20 1978-02-04 Nippon Tokushu Noyaku Seizo Kk Nn44halogenobenzyllnnmethyl*or nonsubstitutedd*cycloalkylln**phenylurea or thiourea compounds* their preparation and fungicides containing the same as active constituents
DE2928485A1 (de) * 1979-07-14 1981-01-29 Bayer Ag Verwendung von harnstoffderivaten als arzneimittel bei der behandlung von fettstoffwechselstoerungen
US4473579A (en) * 1982-01-26 1984-09-25 American Cyanamid Company Antiatherosclerotic tetrasubstituted ureas and thioureas
US4868210A (en) * 1988-03-30 1989-09-19 Warner-Lambert Company Antihyperlipidemic and antiatherosclerotic compounds and compositions
DE68911203T2 (de) * 1988-03-30 1994-04-14 Warner Lambert Co N-[[(2,6-disubstituierte)phenyl]N'- arylalkyl] Harnstoffe als antihypercholesterolemische und antiatherosclerotische Mittel.
IL89997A0 (en) * 1988-04-25 1989-12-15 Lilly Co Eli Propanamine derivatives
JPH02124884A (ja) * 1988-07-08 1990-05-14 Zhongguo Yixuekexueyuan Yaowo Yanjiusuo Ｎ―置換アミド誘導体
CA2010184A1 (fr) * 1989-02-17 1990-08-17 Bharat K. Trivedi Composes d'uree trisubstitues ayant des proprietes antihyperlipidemiques et antiatherosclerotiques
AU629376B2 (en) * 1989-08-04 1992-10-01 Mitsubishi Chemical Corporation 1-phenylalkyl-3-phenylurea derivatives

Also Published As

Publication number Publication date
CA2034673A1 (fr) 1991-07-23
ATE110375T1 (de) 1994-09-15
ES2057608T3 (es) 1994-10-16
DE69103535D1 (de) 1994-09-29
EP0439059A3 (en) 1991-11-13
AU636946B2 (en) 1993-05-13
DE69103535T2 (de) 1995-01-26
EP0439059A2 (fr) 1991-07-31
US5202351A (en) 1993-04-13
KR910014366A (ko) 1991-08-31
JPH05310678A (ja) 1993-11-22
AU6948291A (en) 1991-07-25
EP0439059B1 (fr) 1994-08-24

Similar Documents

Publication Publication Date Title
DK0405233T3 (da) Diphenylurinstofderivater
NZ272015A (en) Treatment of insufficiency of central choline functions using a cyclic amide (substituted 1,3-benzoxazin-2-one derivative)
FI922141A (fi) Analogiamenetelmä uusien hypoglykeemisten oksatsolidiinidionien valmistamiseksi
ZA9710292B (en) Atherosclerosis treatment
PT90623A (pt) Processo para a preparacao de n-heterociclil-4-guanilalquil-benzamidas uteis como inibidores de protease
DK0439059T3 (da) 1-phenylalkyl-3-phenylurinstofderivat
DK0559533T3 (da) Fremgangsmåde til fremstilling af beta-lactamderivat og syntetisk mellemprodukt deraf
KR0184608B1 (en) Novel benzopyran derivative
DE69014775D1 (de) 1-Phenylalkyl-phenylharnstoff-Derivate.
DK0411394T3 (da) Imidazoquinolon-derivater
FI914525A0 (fi) Foerening, anvaendning och framstaellning.
FI824407A0 (fi) Foerfarande foer framstaellning av av vid behandling av magsaor anvaendbara pyrimidinderivat
DE3879058D1 (de) 4-piperidincarboxamid-derivate.
DK0627419T3 (da) Optisk aktive derivater af 1-phenylpyrrolidon og fremgangsmåde til fremstilling deraf
ATE33983T1 (de) N-substituierte tetrahydrothiazine, verfahren zu deren herstellung und deren verwendung als pestizide.